OMED
OncoMed Pharmaceuticals, Inc.
OMED
OMED
Delisted
OMED was delisted on the 22nd of April, 2019.
62 hedge funds and large institutions have $143M invested in OncoMed Pharmaceuticals, Inc. in 2014 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 26 increasing their positions, 21 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
8% less capital invested
Capital invested by funds: $155M → $143M (-$12.3M)
14% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 7
Holders
62
Holding in Top 10
1
Calls
$1.84M
Puts
$295K
Top Buyers
| 1 | +$8.75M | |
| 2 | +$5.72M | |
| 3 | +$1.58M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$1.43M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$1.33M |
Top Sellers
| 1 | -$5.9M | |
| 2 | -$909K | |
| 3 | -$893K | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$892K |
| 5 |
Renaissance Technologies
New York
|
-$361K |